Description
A selective COX-2 inhibitor (IC50s = 22.9 and 0.05 μM for COX-1 and COX-2, respectively); reduces production of IL-1β, TNF-α, and MMP-3 as well as articular cartilage damage in a rabbit model of osteoarthritis at 3 ml of a 0.4% solution; reduces blood glucose and improves renal function and memory deficits in rats with streptozotocin-induced diabetes; displays chemopreventive activity in multiple tumor types via proapoptotic effects that are independent of COX-2 inhibition
Formal name: 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide
Synonyms: SC-58635|YM-177
Molecular weight: 381.4
CAS: 169590-42-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Small Molecule Inhibitors|Cyclooxygenases||Research Area|Cancer|Cell Death|Apoptosis||Research Area|Immunology & Inflammation|Arthritis (Non-autoimmune)||Research Area|Immunology & Inflammation|Inflammatory Lipid Mediators|Prostaglandins||Research Area|Lipid Biochemistry|Cyclooxygenase Pathway